<DOC>
	<DOC>NCT00038077</DOC>
	<brief_summary>The purpose of this study is to determine whether treatment with Toprol-XL for 12 months in asymptomatic heart failure subjects will improve their heart structure and thus prevent the progression to symptomatic disease.</brief_summary>
	<brief_title>Reversal of Ventricular Remodeling With Toprol-XL</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Ventricular Remodeling</mesh_term>
	<mesh_term>Metoprolol</mesh_term>
	<criteria>Diagnosis of stable asymptomatic heart failure. Documented ejection fraction less than 0.40. Must be able to comply with all study procedures. Taken Bblocker therapy for longer than 1 week within 6 months prior to randomization. Have heart problems that would not allow Bblocker therapy. Receiving Bblockers therapy for any medical reason including topical Bblockers that might cause systemic absorption (e.g., glaucoma). Undergone certain heart surgeries, such as, prior heart transplant or cardiomyoplasty. Have certain heart diseases. Pregnant or breast feeding. Unlikely to survive.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>